|Year : 2012 | Volume
| Issue : 4 | Page : 231-236
Role of cholescintigraphy in management of acute acalculous cholecystitis
Shefali M Gokhale1, SD Lokare2, Pankaj Nemade2
1 Department of Nuclear Medicine, Inlaks and Budhrani Hospital, Pune, India
2 Department of Surgery, Inlaks and Budhrani Hospital, Pune, India
|Date of Web Publication||23-Jul-2013|
Shefali M Gokhale
Department of Nuclear Medicine, Inlaks and Budhrani Hospital, 7-9, Koregaon Park, Pune - 411 001
Source of Support: Director Academics, Staff of Nuclear Medicine Department Inlaks and Budhrani hospital, Pune, Conflict of Interest: None
| Abstract|| |
Aim: This study is aimed to evaluate the role of cholescintigraphy in management of acute acalculous cholecystitis. Materials and Methods: A total of thirty two patients who had presented to the surgical out-patient department or referred from in-patient department or intensive care unit between February 2008 and February 2010 were studied. All patients with Ultrasonography abdomen findings of acalculous cholecystitis were included in the study and they underwent cholescintigraphy. Gall bladder ejection fraction (GBEF) was calculated 30 min after fatty meal. Patients who either had non-visualization of gall bladder or GBEF less than 40% were considered to have acalculous cholecystitis on cholescintigraphy. The patients were followed-up for a period of 3 months after the commencement of treatment. Results: Eleven patients had either non-visualization of gall bladder or GBEF < 40%. Of these, six patients underwent cholecystectomy and the rest were medically managed, as patients deferred surgery. 83.33% of post-cholecystectomy patients as against 40% of medically treated patients were symptom free. Twenty one patients had GBEF > 40%, 90.74% of these patients were symptom free at the end of 3 months, with medical management. Conclusion: Cholescintigraphy is an important adjunct in management of patients with acalculous cholecystitis by guiding the course of therapy-surgical management versus medical management.
Keywords: Acute acalculous cholecystitis, cholescintigraphy, gall bladder ejection fraction
|How to cite this article:|
Gokhale SM, Lokare S D, Nemade P. Role of cholescintigraphy in management of acute acalculous cholecystitis. Indian J Nucl Med 2012;27:231-6
|How to cite this URL:|
Gokhale SM, Lokare S D, Nemade P. Role of cholescintigraphy in management of acute acalculous cholecystitis. Indian J Nucl Med [serial online] 2012 [cited 2020 Jan 21];27:231-6. Available from: http://www.ijnm.in/text.asp?2012/27/4/231/115393
| Introduction|| |
Acute acalculous cholecystitis (AAC) is a well-recognized but still poorly understood entity. It accounts for 5-14% of all cases of acute cholecystitis. It is well-known to occur in very sick patients already admitted in intensive care unit (ICU), e.g., after major trauma, burns, sepsis, major non-biliary surgery and after parenteral feeding, with high incidence of complications such as perforation and high mortality. Compromised perfusion of the metabolically active gall bladder mucosa may also be contributory. Other factors such as prolonged hyperalimentation, prolonged suctioning by nasogastric tube, positive pressure ventilatory support, numerous transfusions, use of vasoactive amines and use of morphine analgesia also have been implicated. 
Most large series have observed that AAC occurs in medically compromised patients. The condition most likely results from a gradual increase in bile viscosity, due to prolonged stasis, that leads to a functional obstruction of the cystic duct. AAC, if not managed effectively, tends to have a more fulminant course, frequently associated with gangrene, perforation, and empyema.  Unfortunately, both clinical and laboratory tests lack sensitivity and specificity for arriving at a diagnosis. After AAC is clinically suspected, the next step is to diagnose and evaluate it. The most accessible and portable tool available is the ultrasonography of abdomen.  A hepatobiliary iminodiaceticacid (HIDA) scan is advised by the Rome II Consensus Group to be the next step in patient evaluation.  The aim of our study was to determine the role of cholescintigraphy in management of patients diagnosed to have acalculous cholecystitis on USG abdomen.
| Materials and Methods|| |
Patients inclusion criteria
This added up to a total of 32 patients.
- Patients presenting to the out-patient department (OPD) or referred from in-patient department or ICU during the period between February 2008 and February 2010 were considered.
- Patients with complaints of flatulent dyspepsia, vomiting, fever, upper abdominal pain and showing possibility of cholecystitis.
- USG abdomen findings suggestive of acalculous cholecystitis
The criteria for labeling cholecystitis on USG Abdomen were as per previous reports and studies.  These were:
These patients were then subjected to cholescintigraphy.
- Gall Bladder wall thickness > 4 mm in absence of ascites or hypoalbuminemia.
- Pericholecystic fluid collection.
- Sonographic Murphy's Sign.
- Gall bladder oedema with Sonographic Murphy's Sign and no underlying pathology such as ascites or hypoalbuminemia.
Patients were advised nil per orally for 4 hours (h) prior to the study. Patients fasting for more than 12 h were fed with a standardized meal and were on fast for 4-5 h and then taken up for the study. There was a strict adherence to these criteria. This is because a recently ingested meal stimulates endogenous cholecystokinin production, which continues until the food has emptied from the upper small bowel. The rising serum cholecystokinin (CCK) level causes gall bladder contraction, prevents radiotracer entry and may result in a false positive study for acute cholecystitis. On the other hand, fasting for long hours, causes collection of viscous bile and sludge in the gall bladder (GB), thus preventing radiotracer entry and causing false positive results.
Technetium-99m(Tc-99 m) mebrofenin was administered intravenously (A dose of 5 mCi of Tc-99 m mebrofenin was administered in patients with S. Bilirubin < 2 mg/dl and increased up to 10 mCi in patients with S. Bilirubin > 10 mg/dl). The study was performed on Multispect Dual Head Gamma Camera (Siemens, Germany). Low-energy high-resolution parallel hole collimator was used. Serial static isotime** images of the abdomen were acquired in anterior view, at different time intervals with the patient in supine position, up to delayed 4 h images, if the gall bladder was not visualized. In cases where gall bladder was visualized, pre- and post-fatty meal images were also acquired. Right lateral view of the abdomen was acquired when deemed necessary. Fatty meal was formulated as Humana fatty meal formula,  240 ml containing 20 g fats and 415 kcal. Standardization of this fatty meal with GBEF was done based on readings from ten normal volunteers.
(**It was difficult to acquire dynamic 1-1.5 h. images for patients referred from the ICU. Hence, we standardized the protocol to static isotime images).
Studies were analyzed for hepatic uptake and excretion of tracer in to the biliary system, time to visualization of activity in small-bowel, time of visualization of gall bladder. The physiology of gall bladder contraction has been well described. , Endogenous CCK secreted by the duodenal mucosa in response to fatty meal stimulus peaks during 20-30 min. The CCK levels remain elevated until the meal has passed through the upper small-bowel and promptly return to baseline due to its rapid metabolism (2.5 min serum half-life).  Gall bladder contraction is initiated when the serum CCK reaches a threshold that is considerably lower than the peak CCK.  Simultaneously, CCK relaxes sphincter of Oddi, allowing bile to empty in to small-bowel.
Hence, in patients where in the gall bladder was visualized, gall bladder ejection fraction (GBEF) 30 min post fatty meal was calculated.
GBEF was calculated by the following formula:
Scintigraphic criteria for interpretation as acalculous cholecystitis
- Non-visualization of gall bladder
- If gall bladder was visualized, GBEF < 40%
The following patients were taken up for surgery:
Patient with GBEF > 40% and those with GBEF < 40% but did not consent for surgery, were taken in to the conservative management arm.
- Patients who showed hepatic uptake and excretion of radiopharmaceutical through the common bile duct, however, without visualization of gall bladder until the delayed 4 h image.
- Patient with GBEF < 40%, if they gave an informed consent for surgery.
Patients were followed-up in the OPD for 3 months post-commencement of treatment (medical/surgical). They were assessed for the presence of symptoms, and if so, whether there was an improvement or worsening of symptoms.
In addition, post-operative patients were assessed for surgery related symptoms/complications and wound healing.
In patients with either non-visualized gallbladder or GBEF < 40%, the odds ratio for the different modes of management was calculated.
| Results|| |
- The findings of cholescintigraphy [Figure 1] ] were as follows:
- Non-visualization of GB [Figure 2] - 7 (21.87%).
|Figure 2: Image of cholescintigraphy in patient with non-visualization of gallbladder|
Click here to view
- GBEF < 40% [Figure 3] - 4 (12.5%).
|Figure 3: Image of cholescintigraphy in patient with gall bladder ejection fraction < 40%|
Click here to view
- GBEF > 40% [Figure 4]- 20 (62.5%).
|Figure 4: Image of cholescintigraphy in patient with gall bladder ejection fraction > 40%|
Click here to view
- Rim Sign - 6 (18.75%).
- Duodenogastric reflux - 4 (12.5%).
- Of the patients suspected to have cholecystitis clinically, 32 patients had USG abdomen findings suggestive of acalculous cholecystitis.
- Twenty six of the 32 patients had positive sonographic Murphy's Sign. Out of these 26, 10 were having EF < 40% or non-visualization of Gall Bladder.
- All patients who had pericholecystic fluid collection were having non-visualization of Gall Bladder on cholescintigraphy. One of these patients had finding of gangrenous gall bladder per operatively [Figure 5].
|Figure 5: Gangrenous gall bladder intraoperative photograph in patient with non-visualization of gall bladder on cholescintigraphy|
Click here to view
- GBEF of < 40% or non-visualization of gall bladder were considered as indicators of better post-operative outcome as suggested by many investigators.
Surgical option was given to patients falling in these two categories. However, as some of these patients denied surgery, they were shifted to control arm and managed conservatively. Of the 11 patients in this category, six underwent cholecystectomy [Figure 6] and [Figure 5] were medically managed as per patient's decision. These patients were followed for 3 months and evaluated for symptom relief. Of the surgically treated patients, five were symptomatically better [Table 1]. In the medically treated arm, three out of five patients did not show any improvement in symptoms. Statistically, this does not give a significant 'P' value. However, 83.33% of the surgically treated group showed improvement as against 40% of the medically treated group [Figure 7], [Figure 8].
|Figure 6: Specimen of empyematous gall bladder in patient with gall bladder ejection fraction < 40% on cholescintigraphy|
Click here to view
|Figure 7: Comparison of various treatment groups according to gall bladder ejection fraction in terms of symptomatic improvement on follow-up|
Click here to view
|Figure 8: Comparison of treatment groups in patients with gall bladder ejection fraction < 40%|
Click here to view
|Table 1: Comparison of groups according to ejection fraction and management, on follow-up|
Click here to view
- Twenty-one patients had GBEF > 40% and were managed medically and followed-up. Of the medically managed patients, 19 patients improved while two remained the same symptomatically [Table 1]. Of these two patients, one underwent cholecystectomy for persistence of symptoms. Hence, in this group, the percentage of patients having symptomatic improvement was 90.47% [Figure 2].
- The odds ratio was found to be 7.4 with a confidence interval of 0.46-122.70.
| Discussion|| |
Imaging Studies have played an incremental role in the diagnosis and management of acute cholecystitis. Overall sensitivity and specificity for Hepatobilliary scintigraphy in the diagnosis of acute cholecystitis are 95-100% and 81-100% respectively, whereas the sensitivity and specificity of sonography is reported as 67-93% and 82-100%, respectively. ,, These data consist of a majority of cases of acute calculous cholecystitis. The role of imaging studies in establishing the diagnosis and management of AAC is less established.
A 7 years review at Yale University by Savoca et al.  showed an increasing prevalence of AAC in out-patients with 77% patients developing AAC while at home and 23% while hospitalized. Our study showed 21 patients presenting to out-patients department with AAC which is 65.62%. In-patients consisted 34.38%, out of which 21.88% were in wards and 12.50% in ICU. This data fairly tallies with data provided by Savoca et al. , Some investigators have developed the ultrasonographic scoring system to improve the accuracy in detecting AAC in critically-ill. Two points are given for distention of the gallbladder or thickening of the gallbladder wall, and one point each is given for striated thickening of the gallbladder wall, sludge, or pericholecystic fluid. Scores of six or higher accurately predict acalculous cholecystitis.  The overall sensitivity of ultrasonography for detecting AAC has been reported to range from 67% to 92%, with specificity for more than 90%. 
A Cholescintigraphy scan has been advised by the ROME II Consensus Group to be the next step in patient evaluation. A Cholescintigraphy Scan can be done using CCK infusion or fatty meal provocation if proper attention to meals and measurement sequence has been given. We used fatty meal provocation method as it is more cost-effective, more physiological and easily available. Proper care was taken to time the sequential scans and the meals. However, a major limitation is the unreliable GBEF values in patients with gastroparesis. These patients have a delayed secretion of endogenous CCK and hence underestimation of GBEF. On the other hand, use of sincalide (synthetic C-terminal octapeptide of CCK) is quicker, reliable and reproducible. It permits better standardization of the procedure.
By the ROME II consensus group  criteria, assessment of gall bladder emptying by cholescintigraphy is a decision making tool in the diagnosis of functional gall bladder disorders. They have suggested a limit of GBEF > 40% to call it as normally functioning gallbladder. On the other hand, they also suggested that in presence of normal sonography findings and liver function tests (LFT)/pancreatic enzyme levels and a reduced GBEF, cholecystectomy is recommended. There are three meta-analyses on the issue of predictive value of cholescintigraphy in symptomatic AAC patients. Yap et al.  studied only symptomatic patients with abnormal and normal cholescintigraphy results who underwent surgery. While study by Ponsky et al.  and Mahid et al.  examined outcomes of patients with abnormal cholescintigraphy results who were medically treated compared with those who underwent surgery. These meta-analyses concluded that cholecystectomy is indicated in symptomatic patients with low ejection fraction on cholescintigraphy, however, without gallstones.
Many other authors had tried to address this issue in their work. Our results were comparable to the odds ratio with confidence interval of the work done by Mishkind et al.  [Table 2].The percentage of patients having symptom relief after cholecystectomy, obtained in our study, is comparable to the results obtained in previous studies [Table 3]. Patients with GBEF > 40% who were managed medically were followed up after 3 months and revealed a symptom relief rate of 90.47% which is also comparable with previous studies. A small sample size was one of the limitations of the study. A larger number of patients need to be studied in order to draw statistically significant conclusions. Also randomization of patients would have given more reliable results and conclusions.
| Conclusion|| |
The symptoms of cholecystitis are clearly associated with motility abnormalities of the gall bladder. Cholescintigraphy is a functional study that defines the underlying pathophysiology of the disease and the value of GBEF directly correlates with gall bladder motility. Hence, cholescintigraphy is an important adjunct in management of patients with acalculous cholecystitis. It effectively guides the mode of therapy - surgical management versus medical management. 
| References|| |
|1.||Eriksen K, Reinstrup P. Acute acalculous cholecystitis. Ugeskr Laeger 1994;156:3311-4. |
|2.||Blumgart LH. 1994. Surgery of the Liver and Biliary Tract. Churchil Livingstone, Edinburgh London Madrid Melbourne New York and Tokyo |
|3.||Mark Feldman, Friedman LS, Brandt LJ, Sleisenger and Fordtran's. Gastrointestinal and Liver Disease. 7 th ed. China: Saunders; 2002. Chapter 65, Gallstone disease. p. 1118-1121. |
|4.||Corazziari E. New Rome criteria for functional gastrointestinal disorders. Dig LiverDis. 2000;32:S233-34. |
|5.||Vahid Kakhki, Jangjoo A, Zakavi S, Davoudi Y, Farzadnia M, Pezeshki-Rad M, et al. Can gallbladder ejection fraction measured by fatty meal cholescintigraphy diagnose chronic cholecystitis . Iran J Nucl Med 2011;19:1. |
|6.||Wiener I, Inoue K, Fagan CJ, Lilja P, Watson LC, Thompson JC. Release of cholecystokinin in man: Correlation of blood levels with gallbladder contraction. Ann Surg 1981;194:321-7. |
|7.||Ziessman HA, Muenz LR, Agarwal AK, ZaZa AA. Normal values for sincalide cholescintigraphy: Comparison of two methods. Radiology 2001;221:404-10. |
|8.||Thompson JC, Fender HR, Ramus NI, Villar HV, Rayford PL. Cholecystokinin metabolism in man and dogs. Ann Surg 1975;182(4):496-504. |
|9.||Weissmann HS, Frank M, Rosenblatt R, Goldman M, Freeman LM. Cholescintigraphy, ultrasonography and computerized tomography in the evaluation of biliary tract disorders. Semin Nucl Med 1979;9:22-35. |
|10.||Zeman RK, Burrell MI, Cahow CE, Caride V. Diagnostic utility of cholescintigraphy and ultrasonography in acute cholecystitis. Am J Surg 1981;141:446-51. |
|11.||Ralls PW, Colletti PM, Halls JM, Siemsen JK. Prospective evaluation of 99mTc-IDA cholescintigraphy and gray-scale ultrasound in the diagnosis of acute cholecystitis. Radiology 1982;144:369-71. |
|12.||Savoca PE, Longo WE, Zucker KA, McMillen MM, Modlin IM. The increasing prevalence of acalculous cholecystitis in outpatients. Results of a 7-year study. Ann Surg 1990;211:433-7. |
|13.||Mirvis SE, Vainright JR, Nelson AW, Johnston GS, Shorr R, Rodriguez A, et al. The diagnosis of acute acalculous cholecystitis: A comparison of sonography, scintigraphy, and CT. AJR Am J Roentgenol 1986;147:1171. |
|14.||Yap L, Wycherley AG, Morphett AD, Toouli J. Acalculous biliary pain: Cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy. Gastroenterology 1991;101:786-93. |
|15.||Ponsky TA, DeSagun R, Brody F. Surgical therapy for biliary dyskinesia: A meta-analysis and review of the literature. J Laparoendosc Adv Surg Tech A 2005;15:439-42. |
|16.||Mahid SS, Jafri NS, Brangers BC, Minor KS, Hornung CA, Galandiuk S. Meta-analysis of cholecystectomy in symptomatic patients with positive hepatobiliary iminodiacetic acid scan results without gallstones. Arch Surg 2009;144:180-7. |
|17.||Mishkind MT, Pruitt RF, Bambini DA, Hakenewerth AM, Thomason MH, Zuger JH, et al. Effectiveness of cholecystokinin-stimulated cholescintigraphy in the diagnosis and treatment of acalculous gallbladder disease. Am Surg 1997;63:769-74. |
|18.||Misra DC Jr, Blossom GB, Fink-Bennett D, Glover JL. Results of surgical therapy for biliary dyskinesia. Arch Surg 1991;126:957-60. |
|19.||Khosla R, Singh A, Miedema BW, Marshall JB. Cholecystectomy alleviates acalculous biliary pain in patients with a reduced gallbladder ejection fraction. South Med J 1997;90:1087-90. |
|20.||Middleton GW, Williams JH. Diagnostic accuracy of 99Tcm-HIDA with cholecystokinin and gallbladder ejection fraction in acalculous gallbladder disease. Nucl Med Commun 2001;22:657-61. |
|21.||Yost F, Margenthaler J, Presti M, Burton F, Murayama K. Cholecystectomy is an effective treatment for biliary dyskinesia. Am J Surg 1999;178:462-5. |
|22.||Watson A, Better N, Kalff V, Nottle P, Scelwyn M, Kelly MJ. Cholecystokinin (CCK)-HIDA scintigraphy in patients with suspected gall-bladder dysfunction. Australas Radiol 1994;38:30-3. |
|23.||Skipper K, Sligh S, Dunn E, Schwartz A. Laparoscopic cholecystectomy for an abnormal hepato-iminodiacetic acid scan: A worthwhile procedure. Am Surg 2000;66:30-2. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8]
[Table 1], [Table 2], [Table 3]